NMD4C members awarded CIHR grants for oculopharyngeal dystrophy, spinal muscular atrophy research

The NMD4C is happy to share that two project applications from NMD4C members on oculopharyngeal dystrophy (OPMD) and spinal muscular atrophy (SMA)  have been awarded Canadian Institute of Health Research (CIHR) research grants in their recent round of funding decisions!

 

A comprehensive study of the natural history of OPMD: An essential step towards clinical trial readiness and evidence-based interventions

 

Led by NMD4C investigator Dr. Cynthia Gagnon, this project has been awarded $820, 846 over a 5-year period, and includes fellow NMD4C investigators Dr. Bernard Brais as a principal investigator, Dr. Hanns Lochmüller as a co-applicant, Dr. Homira Osman as a collaborator and Dr. Élise Duchesne, early-career member of the NMD4C, as an investigator. Other NMD4C members on this project include Dr. Luc Hébert as a principal investigator, Dr. Benjamin Gallais as a co-applicant, Claudia Côté and Dr. Xavier Rodrigue as collaborators, and project collaborators Dr. Djamal Barbiche, Dr. Nancy Presse, and Dr. Jean-Denis Brisson.

 

The study involves four data collection sites (Saguenay, Québec, Montréal and Ottawa) and will address the impact of OPMD over time in the lives of those affected by these neuromuscular disorders. The study will involve the use of NMD4C-related activities including the Canadian Neuromuscular Disease Registry, biobanking resources, and the network’s knowledge translation expertise.

 

In addition to dysphagia, the team will document several characteristics related to their physical performances, such as walking capacities and muscle strength. Also, the study will look at their participation in daily activities, such as the ability to move in their house and communities, and to perform sports and leisure activities. The research team will also be able to select the best instruments to assess the key problems in this disorder such as muscle weakness and fatigue.

 

This study will provide essential data to help speed up therapeutic trials in this population by documenting natural history and informing outcome measures selection.  

The scientific summary can be found here!

 

Extracellular vesicles as a biomarker and therapeutic for Spinal Muscular Atrophy

 

Led by NMD4C member Dr. Robin Parks, this project has been awarded $960,076 over a 5-year period and includes Dr. Rashmi Kothary (NMD4C steering committee member), Dr. Jodi Warman Chardon (NMD4C steering committee member) and Dr. Panayotis Vacratsis from the University of Windsor as co-investigators. 

 

 

SMA is a devastating disorder primarily affecting newborns and young children, caused by reduced levels of the survival motor neuron (SMN) protein. Although normally present in all cells of the body, reduced levels of SMN protein results in degeneration of motor neurons, leading to muscle weakness and, in the case of severe disease, death. 

 

A small proportion of SMN protein is naturally released by cells in small “bubbles” called extracellular vesicles (EV). This study will evaluate whether analysis of EV isolated from patient blood can be used as a marker for the disease state, which may allow the development of a blood test to monitor the effectiveness of therapeutics.

 

 

The NMD4C are happy to see members obtaining positive funding decisions in a competitive application process, and would like to congratulate them on their success! The network is proud to have leading Canadian neuromuscular researchers as members and will continue the network’s work in supporting the neuromuscular research community in Canada.

CIHR logo

Read next...

ImPORTND logo with text reading 'new module - skills for patient oriented research'

New Course ‘Skills for Patient Oriented Research’ Added to ImPORTND Training Platform

The third and final module of our patient-oriented research training platform, ImPORTND, is now available! ‘Skills for Patient-Oriented Research’ teaches specific skills to help with patient-oriented research (POR), including how to develop an effective patient engagement plan, share and listen to patient stories, and evaluate project engagement. 

MDC, NMD4C and CSCN fellowships competition is now open

Annual Neuromuscular Postdoctoral Research and Clinical Fellowships Funding Competition Now Open

Our 2024 annual funding competition to award postdoctoral fellowships in neuromuscular disease research, and clinical fellowship awards in neuromuscular medicine and electromyography is now open!

canada-people

Curriculum Group Wraps up Inaugural Fellows’ Training Series

Our national neuromuscular lecture series launched last August 2022 has just wrapped up! The series consisted of a weekly (38 weeks) virtual Royal College CPD-accredited curriculum for neuromuscular fellows presented by subject-matter experts, developed by the curriculum working group together with the directors of fellowship programs across Canada.  

NMD4C and MDC together offer free training and support for research teams and patients to conduct patient oriented research

ImPORTND – Training for Research Teams and Patient and Family Partners to Conduct Patient-Oriented Research in Neuromuscular Diseases

We are partnering with Muscular Dystrophy Canada (MDC) to offer free training and support services for research teams and patients to empower all members of the research team to conduct research that is informed by, and most meaningful to individuals living with neuromuscular disorders. 

NMD4C awarded grant funding from CIHR-IMHA and funding from MDC for a period of 5 years.

Press Release | Neuromuscular Disease Network for Canada Awarded 5-Year Grant from CIHR-IMHA and Funding from MDC to Strengthen Canadian Neuromuscular Research and Care

The NMD4C has received a network grant from CIHR-IMHA and matched funding from MDC, providing funding of $400 000 per year for five years to strengthen the care, research and treatment of neuromuscular diseases for all Canadians.

Ottawa NMD conference poster

Important Deadlines for Ottawa NMD 2023

The Ottawa International Conference on Neuromuscular Disease and Biology (Ottawa NMD 2023) deadline for discounted early-bird registration and abstract submission is June 30th!